Michael Exton
First SEC filing: March 3, 2026 · Latest: March 3, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LXRX | M | 503,263 | · | · | 1,006,527 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2026 | LXRX | F | 204,831 | $1.47 | $301,102 | 298,432 Direct | -40.70% | Disposed | 23.8% (price as of 2026-10-02) |
| Feb. 28, 2026 | LXRX | M | 503,263 | · | · | 503,263 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 12, 2026 | LXRX | A | 1,293,670 | · | · | 1,293,670 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 12, 2026 | LXRX | A | 862,440 | · | · | 862,440 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 13, 2025 | LXRX | A | 1,509,790 | · | · | 1,509,790 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 13, 2025 | LXRX | A | 2,264,690 | · | · | 2,264,690 Direct | · | Acquired | (price as of 2026-10-02) |
| July 8, 2024 | LXRX | A | 1,675,000 | · | · | 1,675,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LXRX | Restricted Stock Units | Common Stock | · | · | 503,263 | Disposed |
| Feb. 12, 2026 | LXRX | Stock Option (Right to Buy) | Common Stock | $1.37 | Feb. 12, 2036 | 1,293,670 | Acquired |
| Feb. 12, 2026 | LXRX | Restricted Stock Units | Common Stock | · | · | 862,440 | Acquired |
| Feb. 13, 2025 | LXRX | Restricted Stock Units | Common Stock | · | · | 1,509,790 | Acquired |
| Feb. 13, 2025 | LXRX | Stock Option (Right to Buy) | Common Stock | $0.70 | Feb. 13, 2035 | 2,264,690 | Acquired |
| July 8, 2024 | LXRX | Stock Option (Right to Buy) | Common Stock | $1.67 | July 8, 2034 | 1,675,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $650,576 | $483,822 | $1,049,304 | · | · | · | $15,020 | $3,553,953 |
| 2024 | $303,726 | $222,600 | · | · | · | · | $493 | $2,835,589 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.